Form 4: MetLife Executive Ramy Tadros Sells Shares Under 10b5-1 Trading Plan
SEC Filing (Form 4)
Ramy Tadros, President of U.S. Business at MetLife, sold 4,026 shares of common stock on March 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Ramy Tadros, a MetLife executive, sold 4,026 shares of MetLife common stock on March 13, 2024.
- The sale was executed under a Rule 10b5-1 trading plan adopted on December 13, 2023.
- The shares were sold at a weighted average price of $71.9025, with individual prices ranging from $71.85 to $72.00.
- Following the transaction, Tadros directly owns 146,981 shares of MetLife common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction was pre-planned under a 10b5-1 trading plan and doesn't necessarily reflect a change in the executive's view of the company's prospects.
Industry Context
Executive stock sales are a common occurrence and are often pre-planned using Rule 10b5-1 trading plans to avoid accusations of insider trading. The sale itself doesn't necessarily indicate a negative outlook for the company.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders due to the small volume of shares sold relative to the company's total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 12/13/2023 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| 03/13/2024 | Date of the transaction (stock sale) |
| 03/14/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.